Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

AngioDynamics Reaffirms FY23 Guidance

Management expects net sales to be in the range of $342 to $348 million, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range

byBenzinga Newsdesk

October 6, 2022

1 minute read

Management expects net sales to be in the range of $342 to $348 million, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range of $0.01 to $0.06 as it continues to invest in new product launches to drive future growth.

Keybanc Maintains Overweight on Janus Intl Gr, Lowers Price Target to $17

By Benzinga Newsdesk

November 10, 5:33 AM

Keybanc analyst Jeffrey Hammond maintains Janus Intl Gr (NYSE:JBI) with a Overweight and lowers the price target from $18 to $17.

JBI

Why Is There a Renewed Interest in Hemp by Textile and Manufacturing Companies?

By Jessica N. Abraham

August 6, 2:39 PM

The truth is, the interest in hemp by textile and manufacturing companies never really left. The demand has always been there, but legal restrictions needed to be lifted so that hemp could be grown in the U.S.

BMWYY

Schwazze Appoints Forrest Hoffmaster As CFO

By Vuk Zdinjak

January 20, 12:16 PM

Medicine Man Technologies operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ), announced changes to its executive financial leadership team in preparation for its growth initiatives in Colorado and New Mexico with the addition of CFO, Forrest Hoffmaster

SHWZ